How tumor-specific modulation frequencies were discovered

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In the spring of 2001, I visited a longtime friend and collaborator, Alexandre Barbault, to share with him my vision of using low levels radiofrequency electromagnetic fields for the treatment of cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Boris C. Pasche
Charles L. Spurr Professor of Medicine, Chairman, Department of Cancer Biology; Director, Comprehensive Cancer Center of Wake Forest University

YOU MAY BE INTERESTED IN

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.
Boris C. Pasche
Charles L. Spurr Professor of Medicine, Chairman, Department of Cancer Biology; Director, Comprehensive Cancer Center of Wake Forest University

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login